FiberNEW2026

Effects of gut microbiota-targeted interventions on pain, physical function, and inflammatory biomarkers in osteoarthritis: a systematic review and meta-analysis of randomized controlled trials.

Li Tao, Long Juncheng, Zhang Yazhong, Luo HongMei et al. — Frontiers in cellular and infection microbiology

Summary

This comprehensive review examined whether interventions targeting gut bacteria, such as probiotics or specific dietary changes, could benefit individuals with osteoarthritis. It found that these approaches might reduce pain, improve physical function, and lower inflammation, offering a potential new way to manage symptoms. However, more research is needed to confirm these promising benefits.

AI-generated summary — read the original

Key points

Interventions aimed at improving gut health, like probiotics and specific diets, were studied for their effects on osteoarthritis.
These approaches showed promise in reducing pain and improving daily physical function.
They also appeared to decrease certain markers of inflammation in the body.
While encouraging, more robust studies are needed to confirm these findings.

What the study looked at

{ "What question the study asked": "Researchers wanted to know if interventions that target the gut microbiome—the community of bacteria in our intestines—could help people suffering from osteoarthritis. Specifically, they investigated whether these interventions could reduce pain, improve physical abilities, and lessen inflammation associated with the condition.", "How it was studied (design/participants)": "This study was a systematic review and meta-analysis, which means the researchers gathered and analyzed data from 18 previously published randomized controlled trials (RCTs). These trials involved over 2,000 adult participants with osteoarthritis and tested various interventions, including probiotics (beneficial live bacteria), prebiotics (fibers that feed beneficial bacteria), synbiotics (a combination of both), or specific dietary modifications.", "What it found": "The combined evidence suggested that these gut-focused interventions might indeed reduce pain and improve physical function, such as walking or daily activities, in individuals with osteoarthritis. They also appeared to lower levels of certain inflammatory markers in the blood. However, the study did not find evidence that these interventions protected cartilage or altered the progression of the disease itself. The authors noted that while promising, the certainty of the evidence varied, and more large-scale, standardized studies are needed for definitive conclusions." }

Dietary takeaway

This review suggests that supporting a healthy gut microbiome, potentially through dietary choices rich in fiber (which acts as prebiotics) like fruits, vegetables, and whole grains, might offer a way to help manage osteoarthritis symptoms. While promising for pain and function, it's crucial to remember that this is not a definitive cure or disease modifier. Always consult a healthcare professional before making significant dietary changes, as one study or review is not enough to establish strong medical recommendations.

Abstract

BACKGROUND: Gut microbiota dysbiosis has been implicated in osteoarthritis (OA) through the gut-joint axis, but the clinical efficacy of gut microbiota-targeted interventions remains unclear. This systematic review and meta-analysis evaluated the effects of these interventions on clinical outcomes and inflammatory biomarkers in OA. METHODS: PubMed, Embase, Web of Science, CNKI, and Wanfang were searched from inception to 20 January 2026 for randomized controlled trials (RCTs) of probiotics, prebiotics, synbiotics, or dietary modification in adults with OA. Primary outcomes were visual analog scale (VAS) pain, Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain, WOMAC function, and WOMAC total score; secondary outcomes included WOMAC stiffness, body weight, knee flexion angle, cartilage oligomeric matrix protein (COMP), high-sensitivity C-reactive protein (hs-CRP), erythrocyte sedimentation rate (ESR), interleukin (IL)-1β, and IL-6. Standardized mean differences (SMDs) with 95% CIs were pooled using random-effects models; risk of bias was assessed with RoB 2.0. Subgroup analyses, univariable meta-regression, trial sequential analysis (TSA), and GRADE were used to grade certainty. RESULTS: Eighteen RCTs (2,080 participants) were included. Interventions reduced VAS pain (SMD = -0.66, 95% CI: -1.27 to -0.06, = 0.03), WOMAC pain (SMD = -0.62, 95% CI: -0.97 to -0.27, = 0.004), WOMAC function (SMD = -0.40, 95% CI: -0.64 to -0.17, = 0.0006), and WOMAC total score (SMD = -0.78, 95% CI: -1.26 to -0.30, = 0.009) and lowered hs-CRP, ESR, and IL-1β. WOMAC stiffness, WOMAC physical function, body weight, knee flexion angle, COMP, and IL-6 did not differ significantly. All 18 trials were rated "some concerns" overall on RoB 2.0. Probiotics showed larger effects than dietary interventions, with appreciable residual heterogeneity. Information accrual reached the required size only for WOMAC pain and WOMAC function; VAS pain, WOMAC total score, and hs-CRP were promising but not yet conclusive. GRADE certainty ranged from high (WOMAC function) to very low (VAS pain); unchanged COMP indicates no support for cartilage protection or disease modification. CONCLUSION: Gut microbiota-targeted interventions, particularly probiotics, may improve pain, physical function, and systemic inflammation in OA. The evidence is compatible with symptomatic benefit but does not support cartilage protection or disease modification. Because certainty ranges from high to very low and information accrual is incomplete for most outcomes, these findings are provisional pending larger standardized RCTs. SYSTEMATIC REVIEW REGISTRATION: https://www.crd.york.ac.uk/PROSPERO/home, identifier CRD42023472181.

View on PubMed →DOI: 10.3389/fcimb.2026.1907672